Page last updated: 2024-08-24

duloxetine hydrochloride and mexiletine

duloxetine hydrochloride has been researched along with mexiletine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Maltsman-Tseikhin, A; Moricca, P; Niv, D1
Banno, K; Inoue, N; Ito, S; Kotera, T; Kyoi, T; Nakamura, A; Nogawa, M; Sasagawa, T; Tajima, K; Takahashi, Y; Ueda, M; Yamashita, Y1
Egashira, N; Higuchi, H; Kaname, T; Kawashiri, T; Shirahama, M; Tsutsumi, K; Ushio, S; Yamamoto, S1
Ahmed, A; Ahmed, M; Austin, S; Barboi, A; Barohn, RJ; Bazant, M; Biliciler, S; Brannagan, T; Bril, V; Brown, A; Burns, T; Cash, T; Dimachkie, MM; Gajewski, B; Hayat, G; Hehir, M; Heitzman, D; Herbelin, LL; Hussain, Y; Iyadurai, S; Jacoby, M; Jawdat, O; Karam, C; Kimminau, KS; Kissel, J; Kolb, N; Kushlaf, H; Kutz, C; Ladha, S; Lewis, R; Li, Y; Lou, JS; Mallonee, W; Memon, A; Mudaranthakam, DP; Pascuzzi, R; Pasnoor, M; Pulley, M; Quan, D; Ralph, J; Ramchandren, S; Salajegheh, K; Saperstein, D; Scelsa, S; Sharma, K; Smith, G; Stino, A; Swenson, A; Thaisetthawatkul, P; Tobon, A; Trivedi, J; Twydell, P; Verma, N; Vu, T; Walk, D; Wicklund, M; Wolfe, G; Wymer, J1
Barohn, RJ; Bhai, SF; Brown, A; Gajewski, B; Kimminau, KS; Pasnoor, M; Waitman, LR1

Reviews

1 review(s) available for duloxetine hydrochloride and mexiletine

ArticleYear
Burning mouth syndrome: will better understanding yield better management?
    Pain practice : the official journal of World Institute of Pain, 2007, Volume: 7, Issue:2

    Topics: Antidepressive Agents; Burning Mouth Syndrome; Duloxetine Hydrochloride; Humans; Mexiletine; Thiophenes

2007

Trials

2 trial(s) available for duloxetine hydrochloride and mexiletine

ArticleYear
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
    JAMA neurology, 2021, 01-01, Volume: 78, Issue:1

    Topics: Adult; Aged; Analgesics; Bayes Theorem; Comparative Effectiveness Research; Duloxetine Hydrochloride; Female; Humans; Male; Mexiletine; Middle Aged; Neuralgia; Nortriptyline; Pain Management; Polyneuropathies; Pregabalin; Treatment Outcome

2021
A secondary analysis of PAIN-CONTRoLS: Pain's impact on sleep, fatigue, and activities of daily living.
    Muscle & nerve, 2022, Volume: 66, Issue:4

    Topics: Activities of Daily Living; Bayes Theorem; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Fatigue; Humans; Mexiletine; Nortriptyline; Pain; Pregabalin; Prospective Studies; Quality of Life; Sleep; Treatment Outcome

2022

Other Studies

3 other study(ies) available for duloxetine hydrochloride and mexiletine

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:1

    Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Drug Interactions; Duloxetine Hydrochloride; Etodolac; gamma-Aminobutyric Acid; Hyperalgesia; Male; Mexiletine; Mice; Paclitaxel; Peripheral Nervous System Diseases; Pregabalin; Thiophenes; Tissue Distribution

2012
Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats.
    Journal of pharmacological sciences, 2015, Volume: 129, Issue:1

    Topics: Administration, Ophthalmic; Analgesics; Animals; Antineoplastic Agents; Axons; Bortezomib; Duloxetine Hydrochloride; Hyperalgesia; Mexiletine; Nerve Degeneration; Neurites; PC12 Cells; Peripheral Nervous System Diseases; Pregabalin; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Tramadol

2015